Pharma Competitor Intelligence Explorer​ (AI Agent)

What is the Pharma Competitor Intelligence (CI) Explorer?

The Pharma Competitor Intelligence Explorer AI Agent helps users quickly survey and monitor originator drugs to support strategic decision-making across product development, licensing, and market entry planning.

Trained on Synapse's drug, patent, clinical, and regulatory data, this AI agent delivers detailed reports covering drug information, patent barriers, patent statements, clinical evidence, infringement risks, regulatory considerations, and market entry recommendations.

Who is it for?

This tool is designed for professionals in:

• Competitive Intelligence (CI)

• Business Development & Licensing

• R&D Project Management (Pharma, CROs, CDMOs)

• Intellectual Property Law

What does it help with?

• Evaluating drug protection and competitive landscapes

• Understanding patent barriers and regulatory considerations

• Reviewing clinical and market intelligence

• Supporting market entry assessments and strategy development

• Replacing the need for costly and time-consuming external consulting services

How does it work?

1. Input your question

   

   • Ask about a specific drug and its regional approval status.

   • The AI agent automatically parses the necessary elements from your question.

2. Generates the analysis:
   The agent assembles a multi-step intelligence workflow:

   a) Drug Information

   • Includes dosage, route of administration (ROA), approval time, structure, and additional product details.

   b) Patent Barrier

   • Reviews registration patents, patent landscape, patent statements, and competitive IP activity.

   c) Clinical Results

   • Summarizes key clinical evidence, efficacy, and safety findings

   d) Legal & Regulatory Assessment

   • Reviews infringement cases, policy considerations, and regulatory warnings

   e) Market Entry Recommendations

   • Identifies opportunities, risks, and strategic considerations

   

3. Creates a final downloadable report and share link

   

Limitations

• Covers only approved drugs (no pipeline or pre-approval data)

• Does not include Canada or Australia